{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/examining-role-genetic-counselors#webpage",
"url": "https://www.fortrea.com/insights/examining-role-genetic-counselors",
"name": "The Role of Genetic Counselors in Cell and Gene Therapy Clinical Trials | Fortrea White Paper",
"description": "This Fortrea white paper explores the role of genetic counselors in cell and gene therapy clinical trials across rare disease and advanced therapy research settings. The content focuses on genetic counselors in cell and gene therapy clinical trials, patient education, genetic counseling support, patient engagement strategies, rare disease research, and participation approaches associated with advanced therapy studies. The white paper highlights factors related to patient understanding, eligibility confirmation, family communication, study participation support, and patient-centered approaches affecting cell and gene therapy clinical trials. Fortrea discusses clinical and patient-centered perspectives designed to support trial education, strengthen patient engagement approaches, and improve participation experiences across advanced therapy research programs. By integrating genetic counseling support with patient engagement and rare disease research approaches, the white paper provides insights into the role of genetic counselors in cell and gene therapy clinical trials and broader patient-centered strategies affecting advanced therapy research."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "The Role of Genetic Counselors in Cell and Gene Therapy Clinical Trials | Fortrea White Paper",
"item": "https://www.fortrea.com/insights/examining-role-genetic-counselors"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/examining-role-genetic-counselors#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/examining-role-genetic-counselors#webpage"
},
"headline": "The Role of Genetic Counselors in Cell and Gene Therapy Clinical Trials | Fortrea White Paper",
"description": "This Fortrea white paper explores the role of genetic counselors in cell and gene therapy clinical trials across rare disease and advanced therapy research settings. The content focuses on genetic counselors in cell and gene therapy clinical trials, patient education, genetic counseling support, patient engagement strategies, rare disease research, and participation approaches associated with advanced therapy studies. The white paper highlights factors related to patient understanding, eligibility confirmation, family communication, study participation support, and patient-centered approaches affecting cell and gene therapy clinical trials. Fortrea discusses clinical and patient-centered perspectives designed to support trial education, strengthen patient engagement approaches, and improve participation experiences across advanced therapy research programs. By integrating genetic counseling support with patient engagement and rare disease research approaches, the white paper provides insights into the role of genetic counselors in cell and gene therapy clinical trials and broader patient-centered strategies affecting advanced therapy research.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2024-10/GettyImages-1207212199_0.webp"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-21",
"dateModified": "2024-10-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/IS_0060_CGT_Genetic%20Counselor_0524_v1%20%281%29.pdf",
"encodingFormat": "application/pdf"
}
}
]
}